Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
103,249
Employees103,249
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
103,249
Employees103,249

RHHBY Key Statistics

Market cap
317.99B
Market cap317.99B
Price-Earnings ratio
28.54
Price-Earnings ratio28.54
Dividend yield
1.75%
Dividend yield1.75%
Average volume
1.85M
Average volume1.85M
High today
$49.35
High today$49.35
Low today
$48.62
Low today$48.62
Open price
$49.15
Open price$49.15
Volume
177.94K
Volume177.94K
52 Week high
$49.35
52 Week high$49.35
52 Week low
$34.10
52 Week low$34.10

Stock Snapshot

As of today, Roche(RHHBY) shares are valued at $48.70. The company's market cap stands at 317.99B, with a P/E ratio of 28.54 and a dividend yield of 1.8%.

During the trading session on 2025-12-10, Roche(RHHBY) shares reached a daily high of $49.35 and a low of $48.62. At a current price of $48.70, the stock is +0.2% higher than the low and still -1.3% under the high.

Trading volume for Roche(RHHBY) stock has reached 177.94K, versus its average volume of 1.85M.

Over the past 52 weeks, Roche(RHHBY) stock has traded between a high of $49.35 and a low of $34.10.

Over the past 52 weeks, Roche(RHHBY) stock has traded between a high of $49.35 and a low of $34.10.

RHHBY News

TipRanks 1d
Roche presents Lunsumio data showing potential across lymphoma treatment lines

The company states: “Roche (RHHBY) announced new data highlighting the potential of Lunsumio, mosunetuzumab, in earlier treatment lines for people living with d...

TipRanks 2d
Roche upgraded to Neutral from Underweight at JPMorgan

JPMorgan analyst Richard Vosser upgraded Roche (RHHBY) to Neutral from Underweight with a price target of CHF 350, up from CHF 230. The firm adjusted ratings in...

Analyst ratings

48%

of 23 ratings
Buy
47.8%
Hold
34.8%
Sell
17.4%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.